IP Library Granted Patent US 9,974,870
Granted Patent B2
US 9,974,870 · App. 14/734,761 · Granted May 22, 2018

Compositions and methods for treatment and imaging using nanoparticles

Inventors: Samuel Achilefu (St. Louis, MO); Kvar Black (St. Louis, MO)
Assignee: WASHINGTON UNIVERSITY
A61K51/088A61K51/1251
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,974,870
App. No.
14/734,761
Granted
May 22, 2018
Kind
B2
Abstract

The present invention encompasses compositions comprising two spectrally distinct radionuclides separated by a site susceptible to cleavage. Compositions of the invention may be used to detect enzyme activity and/or image diseases associated with said enzyme activity.

Claims (14)

1. A composition comprising:

(a) a peptide comprising the hydrophobic amino acid sequence SEQ ID No. 4 (Tyr-Leu-Ala-Ile-Ahx-Pro-Ala) and the hydrophilic amino acid sequence SEQ ID No. 3 (Gly-Arg-Arg-Arg-Orn-Arg-Arg-Lys-Lys-Arg-Lys) separated by the caspase-3 sensitive site comprising the amino acid sequence SEQ ID NO:2 (Asp-Glu-Val-Asp); and

(b) two radionuclides, wherein the spectrally differentiated radionuclides are 125 I and 111 In

wherein the radionuclides are attached to the peptide and separated by the site susceptible to cleavage by caspase-3.

2. The composition of claim 1 , wherein one of the radionuclides is conjugated to a Tyr residue found in the peptide.

3. The composition of claim 1 , wherein one of the radionuclides is conjugated to a chelating agent coupled to the peptide.

4. The composition of claim 3 , wherein the radionuclide is 111 In.

5. The composition of claim 1 , wherein the peptide further comprises a -Lys-Gly-Cys- group and one of the radionuclides is conjugated to the -Lys-Gly-Cys- group found the peptide.

6. A method of detecting enzyme activity in a subject, the method comprising:

a) administering to the subject an effective amount of a composition of claim 1 ;

b) imaging the subject for a signal corresponding to the 125 I and 111 In to determine the biodistribution for the 125 I and 111 In; and

c) comparing the biodistribution of the 125 I to the biodistribution of the 111 In wherein when the biodistribution for the 125 I differs from the biodistribution for the 111 In, enzyme activity is detected.

7. The method of claim 6 , wherein the subject is imaged about 4 to about 48 hours after administration.

8. The method of claim 6 , wherein the subject is imaged using single photon emission computed tomography (SPECT).

Assignments (2)
CONFIRMATORY LICENSE Recorded Jan 13, 2017
From: WASHINGTON UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 041356/0054 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 3, 2016
From: ACHILEFU, SAMUEL; BLACK, KVAR
To: WASHINGTON UNIVERSITY
Reel/Frame 038445/0336 →
Continuity (3)
Provisional Application 62009481 · Jun 9, 2014
Provisional Application 62137628 · Mar 24, 2015
Related Publication 20150352234A1 · Dec 10, 2015